Careers Contact
Careers Contact

Investors

Since 2021, Evaxion has been listed on the Nasdaq Capital Market exchange (ticker code: EVAX). Here you can find all of the latest Evaxion investor insights: our results, upcoming events and news, important shareholder updates and much more.

Latest press releases

Email alerts
View all
Jan 13, 2026

Evaxion expands AI-Immunology™ platform into autoimmune diseases
Jan 7, 2026

Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
Dec 19, 2025

Evaxion provides update on MSD collaboration – retains global rights to Gonorrhea vaccine candidate EVX-B2

Upcoming events & presentations

View all
Mar 5, 2026
|
02:30 PM
|
Virtual
Business update and full year 2025 financial results
Evaxion will provide a business update and report its full year 2025 financial results on Thursday, March 5, 2026, before opening of the Nasdaq CM. Evaxion’s Executive Management will host a conference call and webcast the same day at 14:30 CET/08:30 EST, presenting the update and results as well as taking questions. This event is free, open to the public and encouraged.
Learn more

Latest events & presentations

View all
Jan 12 – Jan 15, 2026
|
San Francisco, United States
18th Biotech Showcase
Coinciding with the 44th annual J.P. Morgan Healthcare Conference, Biotech Showcase takes place on January 12-14, 2026 in San Francisco, CA. It is a leading investor conference that connects private and micro-mid-cap biotech companies with investors and biopharma executives.
Learn more
Q3

Latest quarterly report

View all financial reports
Presentation Presentation Webcast Webcast Transcript Transcript Press release Press release

Contact IR

Mads Kronborg
Vice President, Investor Relations & Communication
Email: mak@evaxion.ai
Telephone: +45 53 54 82 96

For general investor relations inquiries please use the contact form below

Company presentation

Stay in touch

LinkedIn
Follow Evaxion on LinkedIn to engage, connect, and stay informed.
Follow us
Twitter
Join the conversation and stay updated with Evaxion on X.
Follow us
Subscribe to email news alerts
Join our mailing list to get our latest press releases delivered straight to your inbox.
Sign up